Efficacy, Safety, and Tolerability, of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis
Clinical trial NCT05152173 · COMPLETED
Trial details
- NCT number
- NCT05152173
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-29
- Primary completion
- 2023-01-10
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.